Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer Patients

NCT01124435 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Neoplasms

Interventions

DRUG: Carboplatin plus Celecoxib

Sponsor

Catholic University of the Sacred Heart